AVTRAvantor, Inc.
Health Care
Operating Lease, Payments revised down 96.2% for Q3 2025
Operating Lease, Payments·Q3 2025
Major restatement$1.2M▼ 96.2%
was$31.2M
Revised down in a 10-Q.
Verify against SEC filingsShow
As reported$31.2M
Accepted 2025-10-290001628280-25-046936
Restated$1.2M
Accepted 2026-10-280001628280-26-067751
OperatingLeaseCashPayments · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time AVTR — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.